AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

AstraZeneca to acquire biotech firm TeneoTwo in a deal worth more than $1.27 billion

08 Jul 2022

AstraZeneca to acquire Alexion in a $39 bn cash-and-stock deal

23 Dec 2020

India may grant emergency use authorisation for Oxford-AstraZeneca Covid-19 vaccine: report

24 Nov 2020

AstraZeneca Covid-19 vaccine trial volunteer in Brazil dies; testing to continue

26 Oct 2020

Sun Pharma licenses AstraZeneca to sell its oncology drugs in China

06 Nov 2019

AstraZeneca and Merck claim Japanese approval for anti-cancer drug Lynparza

20 Jun 2019

AstraZeneca in $6.9 bn deal with Daiichi Sankyo for cancer drug development

29 Mar 2019

AstraZeneca’s Imfinzi gets Breakthrough Therapy Designation from FDA

31 Jul 2017

AstraZeneca and Merck in $8.5-billion oncology deal

27 Jul 2017

AstraZeneca licenses cancer drug Zoladex to TerSera Therapeutics

21 Feb 2017

AstraZeneca to cut 700 positions

09 Dec 2016

AstraZeneca inks $1bn plus drug development deal with Bicycle Therapeutics

02 Dec 2016

Pfizer to acquire part of AstraZeneca's antibiotics business

24 Aug 2016

AstraZeneca's bid to save Crestor sales fails, court turns down IPR protection request till 2026

21 Jul 2016

AstraZeneca’s last-ditch attempt to protect its statin Crestor failed as a federal judge denied its bid for a restraining order against Indian generic drugmakers

FluMist failed to protect kids and adults against flu

23 Jun 2016

Aspen Pharmacare to buy AstraZeneca’s anaesthetics portfolio for at least $520 mn

09 Jun 2016

AstraZeneca drug awarded orphan status in thyroid cancer

13 May 2016

AstraZeneca, Reckitt Benckiser face investor ire over fat executive pay

02 May 2016

Reckitt Benckiser was fined the equivalent of £885,000 in Australia for misleading consumers after a court ruled that pills that claimed to target ailments such as migraine or back pain were identical

AstraZeneca to sell US rights for its gout drug to Ironwood Pharmaceuticals

26 Apr 2016

AstraZeneca project to sequence 2 mn genomes for new medicines

23 Apr 2016

AstraZeneca licenses hypertension drug to China Medical System for $310 million

01 Mar 2016

AstraZeneca to sell rights to two heart drugs to China Medical for $500 mn

01 Mar 2016

EU clears AstraZeneca’s new 'Brilique’ dosage for extended treatment of heart patients

19 Feb 2016